Ondansetron Hydrochloride And Dextrose

Ondansetron Hydrochloride And Dextrose

Ondansetron Hydrochloride And Dextrose Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

Hypersensitivity reactions have been reported in patients who have exhibited hypersensitivity to other selective 5-HT3 receptor antagonists.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

  1. Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including high-dose cisplatin. Efficacy of the 32-mg single dose beyond 24 hours in these patients has not been established.

History

There is currently no drug history available for this drug.

Other Information

The active ingredient in Ondansetron in 5 % Dextrose Injection is ondansetron hydrochloride (HCl), the racemic form of ondansetron and a selective blocking agent of the serotonin 5-HT3 receptor type. Chemically it is (±) 1, 2, 3, 9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one, monohydrochloride, dihydrate. It has the following structural formula:

Ondansetron structural formula

The empirical formula is C18H19N3O·HCl·2H2O, representing a molecular weight of 365.9.

Ondansetron HCl is a white to off-white powder that is soluble in water and normal saline.

Sterile, Premixed Solution for Intravenous Administration in Single-Dose, Flexible Plastic Containers: Each 50 mL contains ondansetron 32 mg (as the hydrochloride dihydrate); dextrose 2500 mg; and citric acid 26 mg and sodium citrate 11.5 mg as buffers in Water for Injection, USP.

It contains no preservatives. The osmolarity of this solution is 270 mOsm/L (approx.), and the pH is 3 to 4.

The flexible plastic container is fabricated from a specially formulated, plastic film. Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly. Solutions inside the plastic container also can leach out certain chemical components in very small amounts before the expiration period is attained. However, the safety of the plastic has been confirmed by tests in animals according to USP biological standards for plastic containers.

Ondansetron Hydrochloride And Dextrose Manufacturers


  • West-ward Pharmaceutical Corp
    Ondansetron Hydrochloride And Dextrose Injection, Solution [West-ward Pharmaceutical Corp]
  • Pfizer Labs, Division Of Pfizer Inc.
    Ondansetron Hydrochloride And Dextrose Injection, Solution [Pfizer Labs, Division Of Pfizer Inc.]
  • Claris Lifesciences, Inc
    Ondansetron Hydrochloride And Dextrose Injection, Solution [Claris Lifesciences, Inc]

Login To Your Free Account